1 / 32

ROAD + BHR

ROAD + BHR. chronic inflammatory disorder of the airways characterized by an obstruction of airflow, which may be completely or partially reversed with or without specific therapy

cobosa
Download Presentation

ROAD + BHR

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. ROAD + BHR chronic inflammatory disorder of the airways characterized by an obstruction of airflow, which may be completely or partially reversed with or without specific therapy Airway inflammation is associated with airway hyper reactivity or bronchial hyper responsiveness (BHR), which is defined as the inherent tendency of the airways to narrow in response to a variety of stimuli (e.g., environmental allergens and irritants). www.pediatricianonline.in GSMC KEMH

  2. Pathophysiology • Environmental and genetic factors • Allergens, GER, weather change, Allergic rhinitis, sinusitis, and chronic URTI • Airway inflammation, bronchospasm, mucosal edema, and mucus plugs • Increased resistance to airflow and decreased expiratory flow rates • Hyperinflation and later alveolar hypoventilation www.pediatricianonline.in GSMC KEMH

  3. Pathophysiology 2 • In the early stages of an acute episode, ventilation-perfusion mismatch => results in hypoxia, No hypercarbia. • respiratory alkalosis results from hyperventilation. ======================================= • With worsening obstruction and increasing ventilation-perfusion mismatch => carbon dioxide retention • Increased work of breathing, increased oxygen consumption, and increased cardiac output result in metabolic acidosis. Respiratory failure leads to respiratory acidosis. www.pediatricianonline.in GSMC KEMH

  4. New insights in the pathogenesis of asthma • a loss of normal balance between two "opposing" populations of Th lymphocytes • Th1 produce IL-2 and IFN-a, which are critical in cellular defense mechanisms in response to infection. • Th2 produce a family of cytokines (IL-4, -5, -6, -9, and -13) that can mediate allergic inflammation. www.pediatricianonline.in GSMC KEMH

  5. "hygiene hypothesis" of asthma • immune system of the newborn is skewed toward Th2 cytokine generation. • Following birth, environmental stimuli such as infections will activate Th1 responses and • bring the Th1/Th2 relationship to an appropriate balance. www.pediatricianonline.in GSMC KEMH

  6. genetic background of cytokine imbalance • Early asthmatic responses occur via IgE-induced mediator release from mast cells within minutes of exposure and last for 20-30 minutes. • Late asthmatic responses occur 4-12 hours after antigen exposure and result in more severe symptoms that can last for hours and contribute to the duration and severity of the disease. • Inflammatory cell infiltration and inflammatory mediators play a role in the late asthmatic response. www.pediatricianonline.in GSMC KEMH

  7. prevalence • Was 5%, and it has increased 20-40% in the past decade • Worldwide, 130 million people have asthma. • The prevalence is 8-10 times higher in developed countries (eg, United States, Great Britain, Australia, New Zealand) than in the developing countries. • Before puberty, the prevalence is 3 times higher in boys than in girls. • In most children, asthma develops before they are aged 5 years www.pediatricianonline.in GSMC KEMH

  8. Clinical patterns • Among infants, 20% have wheezing with only upper respiratory tract infections (URTIs), and 60% no longer have wheezing when they are aged 6 years • "transient wheezers" • Children in whom wheezing begins early, in conjunction with allergies, are more likely to have wheezing when they are aged 6 and 11 years. • Similarly, children in whom wheezing begins after they are aged 6 years often have allergies, and the wheezing is more likely to continue when they are aged 11 years. • Cough variant asthma, exerxise induced asthma, nocturnal asthma www.pediatricianonline.in GSMC KEMH

  9. National Asthma Education and Prevention Program US"Guidelines for the Diagnosis and Management of Asthma" • (a) episodic symptoms of airflow obstruction are present, • (b) airflow obstruction or symptoms are at least partially reversible, and • (c) alternative diagnoses are excluded. www.pediatricianonline.in GSMC KEMH

  10. severity of asthma • Mild intermittent, • Mild persistent, • Moderate persistent, or • Severe persistent, • According to the frequency and severity of symptoms, including nocturnal symptoms, characteristics of acute episodes, and pulmonary function. www.pediatricianonline.in GSMC KEMH

  11. mild intermittent • symptoms fewer < than 2 times a week • pulmonary function is normal between exacerbations. • Exacerbations are brief, lasting from a few hours to a few days • Nighttime symptoms occur less than twice a month • variation in peak expiratory flow (PEF) is less than <20%. www.pediatricianonline.in GSMC KEMH

  12. mild persistent • Symptoms more than 2 times a week but less than once a day. • Exacerbations may affect activity. • Nighttime symptoms occur more than twice a month. • (FEV1) is less than 80% of the predicted value, and the variation in PEF is 20-30%. www.pediatricianonline.in GSMC KEMH

  13. moderate persistent • Daily symptoms • Exacerbations more than 2 times a week and last for days. affect activity • Nocturnal symptoms occur more than once a week • FEV1 60-80% of the predicted values, and PEF varies by more than 30%. www.pediatricianonline.in GSMC KEMH

  14. severe persistent • Continuous or frequent symptoms • limited physical activity, and • frequent nocturnal symptoms • FEV1 less than 60% of the predicted values, and varies by more than 30%. www.pediatricianonline.in GSMC KEMH

  15. Wheezing ≠ asthma, not synonymous • A musical, high-pitched, whistling sound produced by turbulence • Initially, wheezing is only end expiratory => then throughout expiration. => during inspiration => During a most severe episode, wheezing may be absent • Asthma can occur without wheezing • Wheezing can be associated with other causes of airway obstruction • Patients with vocal cord dysfunction have a inspiratory monophonic wheeze (different from the polyphonic wheeze in asthma), which is heard best over the laryngeal area in the neck. Patients with bronchomalacia and tracheomalacia also have a monophonic wheeze. • In exercise-induced or nocturnal asthma, wheezing may be present after exercise or during the night, respectively. www.pediatricianonline.in GSMC KEMH

  16. symptoms • typical symptoms of wheezing, coughing, and chest tightness • shortness of breath, and • coughing after exposure to allergens, environmental irritants, viruses, cold air, or exercise. • with chronic asthma, airflow limitation may be only partially reversible because of airway remodeling www.pediatricianonline.in GSMC KEMH

  17. Coughing • May be the only symptom • Especially in cases of exercise-induced or nocturnal asthma. • Nonproductive and nonparoxysmal • Coughing may be present with wheezing • Children with nocturnal asthma tend to cough after midnight, during the early hours of morning. www.pediatricianonline.in GSMC KEMH

  18. Recurrent respiratory….=> HRAD • history of recurrent bronchitis, • bronchiolitis, or • pneumonia; • a persistent cough with colds; and/or • recurrent croup or chest rattling. • chronic or recurrent bronchitis www.pediatricianonline.in GSMC KEMH

  19. Clinical grading of breathlessness • Breathless on walking • Breathless on talking • Breathless at rest • Breathless => impending respiratory failure www.pediatricianonline.in GSMC KEMH

  20. physical findings • normal findings • signs of chronic respiratory distress and chronic hyperinflation • Signs of atopy or allergic rhinitis • prolongation of the expiratory phase, expiratory wheezing, coarse crackles, or unequal breath sounds. www.pediatricianonline.in GSMC KEMH

  21. physical findings www.pediatricianonline.in GSMC KEMH

  22. Investigations : > 5 yr age • PFT –spirometry • an obstructive defect is present in the form of normal forced vital capacity (FVC), reduced FEV1, and reduced forced expiratory flow over 25-75% of the FVC (FEF 25-75). The flow-volume loop can be concave. • PFT - plethysmography • an increased total lung capacity (TLC) at plethysmography. Increased residual volume (RV) and functional residual capacity (FRC) • Documentation of reversibility of airway obstruction after bronchodilator therapy is central to the definition of asthma. • Bronchial provocation tests may be performed to diagnose BHR Bronchial provocation tests may be performed to diagnose BHR with methacholine. www.pediatricianonline.in GSMC KEMH

  23. Other investigations • Eosinophil counts and IgE levels • fraction of exhaled nitric oxide (FeNO) as a noninvasive marker of airway inflammation • Chest radiography • Paranasal sinus radiography or CT scanning • Allergy testing www.pediatricianonline.in GSMC KEMH

  24. goals of asthma therapy • prevent chronic and troublesome symptoms, • maintain normal or near-normal pulmonary function, • maintain normal physical activity levels (including exercise), • prevent recurrent exacerbations of asthma, and • minimize the need for emergency department visits or hospitalizations, • provide optimal pharmacotherapy with minimal or no adverse effects, and • meet the family's expectations for asthma care. www.pediatricianonline.in GSMC KEMH

  25. Nonpharma treatment • Allergen avoidance • Sitting posture with arm support • Open mouth breathing during an episode • Avoid congested crowded or high altitude areas with relative hypoxia www.pediatricianonline.in GSMC KEMH

  26. Pharmacologic management • inhaled corticosteroids, • inhaled cromolyn or nedocromil, • long-acting bronchodilators, • theophylline, • leukotriene modifiers, • anti-IgE antibodies Relief medications include • short-acting bronchodilators, systemic corticosteroids, and ipratropium. www.pediatricianonline.in GSMC KEMH

  27. Plan: inhaled medicines > systemic www.pediatricianonline.in GSMC KEMH

  28. Inhalation devices www.pediatricianonline.in GSMC KEMH

  29. www.pediatricianonline.in GSMC KEMH

  30. www.pediatricianonline.in GSMC KEMH

  31. www.pediatricianonline.in GSMC KEMH

  32. Visit • http://www.peditips.com • for various pediatric medicine related tips. www.pediatricianonline.in GSMC KEMH

More Related